{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T08:04:40Z","timestamp":1795161880535,"version":"4.10.3"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974171"],"award-info":[{"award-number":["81974171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients suffering from chronic pain often also exhibit depression symptoms. Soluble epoxide hydrolase (sEH) inhibitors can decrease blood levels of inflammatory cytokines. However, whether inhibiting sEH signaling is beneficial for the comorbidity of pain and depression is unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>According to a sucrose preference test (SPT),\u00a0spared nerve injury (SNI) mice were classified into pain with or without an anhedonia phenotype. Then, sEH protein expression and inflammatory cytokines were assessed in selected tissues. Furthermore, we used sEH inhibitor TPPU to determine the role of sEH in chronic pain and depression. Importantly, agonists and antagonists of aryl hydrocarbon receptor (AHR) and translocator protein (TSPO) were used to explore the pathogenesis of sEH signaling.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In anhedonia-susceptible mice, the tissue levels of sEH were significantly increased in the medial prefrontal cortex (mPFC), hippocampus, spinal cord, liver, kidney, and gut. Importantly, serum CYP1A1 and inflammatory cytokines, such as interleukin 1\u03b2 (IL-1\u03b2) and the tumor necrosis factor \u03b1 (TNF-\u03b1), were increased simultaneously. TPPU improved the scores of mechanical withdrawal threshold (MWT) and SPT, and decreased the levels of serum CYP1A1 and inflammatory cytokines. AHR antagonist relieved the anhedonia behaviors but not the algesia behaviors in anhedonia-susceptible mice, whereas an AHR agonist abolished the antidepressant-like effect of TPPU. In addition, a TSPO agonist exerted a similar therapeutic effect to that of TPPU, whereas pretreatment with a TSPO antagonist abolished the antidepressant-like and analgesic effects of TPPU.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>sEH underlies the mechanisms of the comorbidity of chronic pain and depression and that TPPU exerts a beneficial effect on anhedonia behaviors in a pain model via AHR and TSPO signaling.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-023-03917-x","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T16:30:36Z","timestamp":1675355436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The soluble epoxide hydrolase inhibitor TPPU improves comorbidity of chronic pain and depression via the AHR and TSPO signaling"],"prefix":"10.1186","volume":"21","author":[{"given":"Ailin","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy B.","family":"McReynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoli","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Hammock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1540-4385","authenticated-orcid":false,"given":"Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"issue":"Suppl 1","key":"3917_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/j.pain.0000000000000775","volume":"158","author":"RB Fillingim","year":"2017","unstructured":"Fillingim RB. Individual differences in pain: understanding the mosaic that makes pain personal. Pain. 2017;158(Suppl 1):11\u20138.","journal-title":"Pain"},{"issue":"8","key":"3917_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.biopsych.2018.05.007","volume":"84","author":"C Yang","year":"2018","unstructured":"Yang C, et al. AMPA receptor activation-independent antidepressant actions of ketamine metabolite (S)-norketamine. Biol Psychiatry. 2018;84(8):591\u2013600.","journal-title":"Biol Psychiatry"},{"issue":"4","key":"3917_CR3","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00213-021-05780-4","volume":"238","author":"N Yin","year":"2021","unstructured":"Yin N, et al. The role of microglia in chronic pain and depression: innocent bystander or culprit? Psychopharmacology. 2021;238(4):949\u201358.","journal-title":"Psychopharmacology"},{"issue":"11","key":"3917_CR4","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1097\/j.pain.0000000000001305","volume":"159","author":"G Mazereeuw","year":"2018","unstructured":"Mazereeuw G, Sullivan MD, Juurlink DN. Depression in chronic pain: might opioids be responsible? Pain. 2018;159(11):2142\u20135.","journal-title":"Pain"},{"issue":"2","key":"3917_CR5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","volume":"107","author":"E Beurel","year":"2020","unstructured":"Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107(2):234\u201356.","journal-title":"Neuron"},{"issue":"6312","key":"3917_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1126\/science.aaf8924","volume":"354","author":"RR Ji","year":"2016","unstructured":"Ji RR, Chamessian A, Zhang YQ. Pain regulation by non-neuronal cells and inflammation. Science. 2016;354(6312):572\u20137.","journal-title":"Science"},{"issue":"2","key":"3917_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","volume":"129","author":"RR Ji","year":"2018","unstructured":"Ji RR, et al. Neuroinflammation and central sensitization in chronic and widespread pain. Anesthesiology. 2018;129(2):343\u201366.","journal-title":"Anesthesiology"},{"issue":"1","key":"3917_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00540-018-2579-4","volume":"33","author":"M Matsuda","year":"2019","unstructured":"Matsuda M, Huh Y, Ji RR. Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain. J Anesth. 2019;33(1):131\u20139.","journal-title":"J Anesth"},{"issue":"1\u20133","key":"3917_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jad.2009.04.027","volume":"120","author":"B Dean","year":"2010","unstructured":"Dean B, et al. Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder. J Affect Disord. 2010;120(1\u20133):245\u20138.","journal-title":"J Affect Disord"},{"issue":"1","key":"3917_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0163-7827(03)00049-3","volume":"43","author":"AA Spector","year":"2004","unstructured":"Spector AA, et al. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog Lipid Res. 2004;43(1):55\u201390.","journal-title":"Prog Lipid Res"},{"key":"3917_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.plipres.2013.11.003","volume":"53","author":"G Zhang","year":"2014","unstructured":"Zhang G, Kodani S, Hammock BD. Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer. Prog Lipid Res. 2014;53:108\u201323.","journal-title":"Prog Lipid Res"},{"issue":"5431","key":"3917_CR12","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","volume":"285","author":"K Node","year":"1999","unstructured":"Node K, et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science. 1999;285(5431):1276\u20139.","journal-title":"Science"},{"issue":"7","key":"3917_CR13","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1089\/hum.2011.135","volume":"23","author":"G Zhao","year":"2012","unstructured":"Zhao G, et al. Delivery of AAV2-CYP2J2 protects remnant kidney in the 5\/6-nephrectomized rat via inhibition of apoptosis and fibrosis. Hum Gene Ther. 2012;23(7):688\u201399.","journal-title":"Hum Gene Ther"},{"issue":"10","key":"3917_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026591","volume":"6","author":"J Bystrom","year":"2011","unstructured":"Bystrom J, et al. Endogenous epoxygenases are modulators of monocyte\/macrophage activity. PLoS ONE. 2011;6(10): e26591.","journal-title":"PLoS ONE"},{"key":"3917_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.prostaglandins.2016.05.004","volume":"125","author":"H Huang","year":"2016","unstructured":"Huang H, Weng J, Wang MH. EETs\/sEH in diabetes and obesity-induced cardiovascular diseases. Prostaglandins Other Lipid Mediat. 2016;125:80\u20139.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"2","key":"3917_CR16","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.neuroscience.2009.06.033","volume":"163","author":"A Marowsky","year":"2009","unstructured":"Marowsky A, et al. Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism. Neuroscience. 2009;163(2):646\u201361.","journal-title":"Neuroscience"},{"issue":"9","key":"3917_CR17","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jpain.2014.05.008","volume":"15","author":"K Wagner","year":"2014","unstructured":"Wagner K, et al. Soluble epoxide hydrolase inhibition is antinociceptive in a mouse model of diabetic neuropathy. J Pain. 2014;15(9):907\u201314.","journal-title":"J Pain"},{"issue":"19","key":"3917_CR18","doi-asserted-by":"publisher","first-page":"7067","DOI":"10.1021\/jm100691c","volume":"53","author":"TE Rose","year":"2010","unstructured":"Rose TE, et al. 1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain. J Med Chem. 2010;53(19):7067\u201375.","journal-title":"J Med Chem"},{"issue":"10","key":"3917_CR19","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1080\/14728222.2016.1226284","volume":"20","author":"K Hashimoto","year":"2016","unstructured":"Hashimoto K. Soluble epoxide hydrolase: a new therapeutic target for depression. Expert Opin Ther Targets. 2016;20(10):1149\u201351.","journal-title":"Expert Opin Ther Targets"},{"issue":"8","key":"3917_CR20","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1111\/ejn.15150","volume":"53","author":"J Wu","year":"2021","unstructured":"Wu J, et al. Inhibition of soluble epoxide hydrolase (sEH) protects hippocampal neurons and reduces cognitive decline in type 2 diabetic mice. Eur J Neurosci. 2021;53(8):2532\u201340.","journal-title":"Eur J Neurosci"},{"issue":"13","key":"3917_CR21","doi-asserted-by":"publisher","first-page":"E1944","DOI":"10.1073\/pnas.1601532113","volume":"113","author":"Q Ren","year":"2016","unstructured":"Ren Q, et al. Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress. Proc Natl Acad Sci USA. 2016;113(13):E1944\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3917_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010013","author":"J Gautheron","year":"2020","unstructured":"Gautheron J, J\u00e9ru I. The multifaceted role of epoxide hydrolases in human health and disease. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms22010013.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3917_CR23","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.jid.2020.11.024","volume":"141","author":"M Kyoreva","year":"2021","unstructured":"Kyoreva M, et al. CYP1A1 enzymatic activity influences skin inflammation via regulation of the AHR pathway. J Invest Dermatol. 2021;141(6):1553-1563.e3.","journal-title":"J Invest Dermatol"},{"key":"3917_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101530","volume":"34","author":"CFA Vogel","year":"2020","unstructured":"Vogel CFA, et al. The aryl hydrocarbon receptor as a target of environmental stressors - Implications for pollution mediated stress and inflammatory responses. Redox Biol. 2020;34: 101530.","journal-title":"Redox Biol"},{"key":"3917_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21061983","author":"NA Ramos-Garc\u00eda","year":"2020","unstructured":"Ramos-Garc\u00eda NA, et al. Aryl hydrocarbon receptor in post-mortem hippocampus and in serum from young, elder, and Alzheimer\u2019s patients. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21061983.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"3917_CR26","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nrd2875","volume":"8","author":"JD Imig","year":"2009","unstructured":"Imig JD, Hammock BD. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov. 2009;8(10):794\u2013805.","journal-title":"Nat Rev Drug Discov"},{"key":"3917_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","volume":"53","author":"C Morisseau","year":"2013","unstructured":"Morisseau C, Hammock BD. Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Annu Rev Pharmacol Toxicol. 2013;53:37\u201358.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3917_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19123851","author":"DR Neavin","year":"2018","unstructured":"Neavin DR, et al. The role of the aryl hydrocarbon receptor (AHR) in immune and inflammatory diseases. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19123851.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3917_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12974-019-1572-7","volume":"16","author":"WC Chen","year":"2019","unstructured":"Chen WC, et al. Aryl hydrocarbon receptor modulates stroke-induced astrogliosis and neurogenesis in the adult mouse brain. J Neuroinflam. 2019;16(1):187.","journal-title":"J Neuroinflam"},{"issue":"4","key":"3917_CR30","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s12031-019-01454-1","volume":"70","author":"D Zhou","year":"2020","unstructured":"Zhou D, Ji L, Chen Y. TSPO Modulates IL-4-Induced Microglia\/Macrophage M2 Polarization via PPAR-\u03b3 Pathway. J Mol Neurosci. 2020;70(4):542\u20139.","journal-title":"J Mol Neurosci"},{"issue":"2","key":"3917_CR31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1055\/s-0034-1398507","volume":"48","author":"L Wolf","year":"2015","unstructured":"Wolf L, et al. Enhancing neurosteroid synthesis\u2013relationship to the pharmacology of translocator protein (18 kDa) (TSPO) ligands and benzodiazepines. Pharmacopsychiatry. 2015;48(2):72\u20137.","journal-title":"Pharmacopsychiatry"},{"key":"3917_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.692917","volume":"12","author":"B Xiong","year":"2021","unstructured":"Xiong B, et al. Identification of Koumine as a translocator protein 18 kDa positive allosteric modulator for the treatment of inflammatory and neuropathic pain. Front Pharmacol. 2021;12: 692917.","journal-title":"Front Pharmacol"},{"key":"3917_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.brainres.2009.06.043","volume":"1286","author":"H Hernstadt","year":"2009","unstructured":"Hernstadt H, et al. Spinal translocator protein (TSPO) modulates pain behavior in rats with CFA-induced monoarthritis. Brain Res. 2009;1286:42\u201352.","journal-title":"Brain Res"},{"issue":"1","key":"3917_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13024-021-00435-6","volume":"16","author":"V Roca-Agujetas","year":"2021","unstructured":"Roca-Agujetas V, et al. Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer\u2019s disease. Mol Neurodegener. 2021;16(1):15.","journal-title":"Mol Neurodegener"},{"key":"3917_CR35","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202059","author":"JM Navia-Pelaez","year":"2021","unstructured":"Navia-Pelaez JM, et al. Normalization of cholesterol metabolism in spinal microglia alleviates neuropathic pain. J Exp Med. 2021. https:\/\/doi.org\/10.1084\/jem.20202059.","journal-title":"J Exp Med"},{"key":"3917_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12990-015-0013-6","volume":"11","author":"DS Wang","year":"2015","unstructured":"Wang DS, et al. Anxiolytic-like effects of translocator protein (TSPO) ligand ZBD-2 in an animal model of chronic pain. Mol Pain. 2015;11:16.","journal-title":"Mol Pain"},{"issue":"4","key":"3917_CR37","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1515\/hsz-2013-0251","volume":"395","author":"L Shen","year":"2014","unstructured":"Shen L, et al. A potent soluble epoxide hydrolase inhibitor, t-AUCB, modulates cholesterol balance and oxidized low density lipoprotein metabolism in adipocytes in vitro. Biol Chem. 2014;395(4):443\u201351.","journal-title":"Biol Chem"},{"key":"3917_CR38","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fnmol.2019.00325","volume":"12","author":"MF Domingues","year":"2019","unstructured":"Domingues MF, et al. Soluble epoxide hydrolase and brain cholesterol metabolism. Front Mol Neurosci. 2019;12:325.","journal-title":"Front Mol Neurosci"},{"issue":"4","key":"3917_CR39","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/mp.2009.91","volume":"15","author":"GJ Norman","year":"2010","unstructured":"Norman GJ, et al. Stress and IL-1beta contribute to the development of depressive-like behavior following peripheral nerve injury. Mol Psychiatry. 2010;15(4):404\u201314.","journal-title":"Mol Psychiatry"},{"issue":"1\u20132","key":"3917_CR40","doi-asserted-by":"publisher","first-page":"14.e1","DOI":"10.1016\/j.pain.2005.10.036","volume":"122","author":"AF Bourquin","year":"2006","unstructured":"Bourquin AF, et al. Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse. Pain. 2006;122(1\u20132):14.e1-14.","journal-title":"Pain"},{"key":"3917_CR41","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3389\/fphar.2018.00887","volume":"9","author":"S Li","year":"2018","unstructured":"Li S, et al. Role of Keap1-Nrf2 signaling in anhedonia symptoms in a rat model of chronic neuropathic pain: improvement with sulforaphane. Front Pharmacol. 2018;9:887.","journal-title":"Front Pharmacol"},{"issue":"4","key":"3917_CR42","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1021\/acs.chemrestox.8b00371","volume":"32","author":"A Mohammadi-Bardbori","year":"2019","unstructured":"Mohammadi-Bardbori A, Omidi M, Arabnezhad MR. Impact of CH223191-induced mitochondrial dysfunction on its aryl hydrocarbon receptor agonistic and antagonistic activities. Chem Res Toxicol. 2019;32(4):691\u20137.","journal-title":"Chem Res Toxicol"},{"issue":"4","key":"3917_CR43","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1096\/fj.201700853R","volume":"32","author":"X Zang","year":"2018","unstructured":"Zang X, et al. Regulation of proinflammatory monocyte activation by the kynurenine-AhR axis underlies immunometabolic control of depressive behavior in mice. Faseb j. 2018;32(4):1944\u201356.","journal-title":"Faseb j"},{"key":"3917_CR44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neuropharm.2017.06.023","volume":"125","author":"L Li","year":"2017","unstructured":"Li L, et al. Overexpression of the 18 kDa translocator protein (TSPO) in the hippocampal dentate gyrus produced anxiolytic and antidepressant-like behavioural effects. Neuropharmacology. 2017;125:117\u201328.","journal-title":"Neuropharmacology"},{"issue":"7","key":"3917_CR45","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/sj.bjp.0705681","volume":"142","author":"A Kita","year":"2004","unstructured":"Kita A, et al. Antianxiety and antidepressant-like effects of AC-5216, a novel mitochondrial benzodiazepine receptor ligand. Br J Pharmacol. 2004;142(7):1059\u201372.","journal-title":"Br J Pharmacol"},{"key":"3917_CR46","first-page":"221","volume-title":"Vitro Methods","author":"G He","year":"2014","unstructured":"He G, et al. Cell-Based Assays for Identification of Aryl Hydrocarbon Receptor (AhR) Activators, in Optimization in Drug Discovery. In: Caldwell GW, Yan Z, editors., et al., Vitro Methods. Totowa, NJ: Humana Press; 2014. p. 221\u201335."},{"key":"3917_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17249515","author":"J Bu","year":"2020","unstructured":"Bu J, et al. Comparative study of hydrochemical classification based on different hierarchical cluster analysis methods. Int J Environ Res Public Health. 2020. https:\/\/doi.org\/10.3390\/ijerph17249515.","journal-title":"Int J Environ Res Public Health"},{"issue":"Suppl 1","key":"3917_CR48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/j.pain.0000000000001296","volume":"159","author":"BA Kohrt","year":"2018","unstructured":"Kohrt BA, Griffith JL, Patel V. Chronic pain and mental health: integrated solutions for global problems. Pain. 2018;159(Suppl 1):85\u201390.","journal-title":"Pain"},{"issue":"9","key":"3917_CR49","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S2215-0366(20)30099-7","volume":"7","author":"E Schramm","year":"2020","unstructured":"Schramm E, et al. Review of dysthymia and persistent depressive disorder: history, correlates, and clinical implications. Lancet Psychiatry. 2020;7(9):801\u201312.","journal-title":"Lancet Psychiatry"},{"issue":"10","key":"3917_CR50","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41593-019-0468-2","volume":"22","author":"W Zhou","year":"2019","unstructured":"Zhou W, et al. A neural circuit for comorbid depressive symptoms in chronic pain. Nat Neurosci. 2019;22(10):1649\u201358.","journal-title":"Nat Neurosci"},{"issue":"1","key":"3917_CR51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4088\/JCP.08m04114","volume":"70","author":"P Lee","year":"2009","unstructured":"Lee P, et al. Frequency of painful physical symptoms with major depressive disorder in asia: relationship with disease severity and quality of life. J Clin Psychiatry. 2009;70(1):83\u201391.","journal-title":"J Clin Psychiatry"},{"issue":"1\u20132","key":"3917_CR52","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jad.2010.10.022","volume":"130","author":"L Ag\u00fcera-Ortiz","year":"2011","unstructured":"Ag\u00fcera-Ortiz L, et al. Pain as a symptom of depression: prevalence and clinical correlates in patients attending psychiatric clinics. J Affect Disord. 2011;130(1\u20132):106\u201312.","journal-title":"J Affect Disord"},{"issue":"20","key":"3917_CR53","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1001\/archinte.163.20.2433","volume":"163","author":"MJ Bair","year":"2003","unstructured":"Bair MJ, et al. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163(20):2433\u201345.","journal-title":"Arch Intern Med"},{"issue":"11","key":"3917_CR54","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1136\/jnnp.74.11.1587","volume":"74","author":"LS Williams","year":"2003","unstructured":"Williams LS, et al. Prevalence and impact of depression and pain in neurology outpatients. J Neurol Neurosurg Psychiatry. 2003;74(11):1587\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"3917_CR55","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0006-3223(03)00545-6","volume":"54","author":"LC Campbell","year":"2003","unstructured":"Campbell LC, Clauw DJ, Keefe FJ. Persistent pain and depression: a biopsychosocial perspective. Biol Psychiatry. 2003;54(3):399\u2013409.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"3917_CR56","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1097\/ALN.0000000000000351","volume":"121","author":"AM Le","year":"2014","unstructured":"Le AM, et al. AMPAkines have novel analgesic properties in rat models of persistent neuropathic and inflammatory pain. Anesthesiology. 2014;121(5):1080\u201390.","journal-title":"Anesthesiology"},{"issue":"2","key":"3917_CR57","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00406-018-0909-z","volume":"270","author":"X Fang","year":"2020","unstructured":"Fang X, et al. Brain-derived neurotrophic factor-TrkB signaling in the medial prefrontal cortex plays a role in the anhedonia-like phenotype after spared nerve injury. Eur Arch Psychiatry Clin Neurosci. 2020;270(2):195\u2013205.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3917_CR58","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.3389\/fimmu.2019.02525","volume":"10","author":"M Zheng","year":"2019","unstructured":"Zheng M, Tian Z. Liver-mediated adaptive immune tolerance. Front Immunol. 2019;10:2525.","journal-title":"Front Immunol"},{"key":"3917_CR59","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev-physiol-021317-121134","volume":"80","author":"AJ Rucker","year":"2018","unstructured":"Rucker AJ, Rudemiller NP, Crowley SD. Salt, hypertension, and immunity. Annu Rev Physiol. 2018;80:283\u2013307.","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"3917_CR60","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/gutjnl-2020-323020","volume":"70","author":"YK Yeoh","year":"2021","unstructured":"Yeoh YK, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70(4):698\u2013706.","journal-title":"Gut"},{"issue":"2","key":"3917_CR61","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/ALN.0000000000000101","volume":"120","author":"R Zhang","year":"2014","unstructured":"Zhang R, et al. Mechanisms of acupuncture-electroacupuncture on persistent pain. Anesthesiology. 2014;120(2):482\u2013503.","journal-title":"Anesthesiology"},{"issue":"3","key":"3917_CR62","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/ejp.939","volume":"21","author":"K Wagner","year":"2017","unstructured":"Wagner K, et al. Epoxy fatty acids mediate analgesia in murine diabetic neuropathy. Eur J Pain. 2017;21(3):456\u201365.","journal-title":"Eur J Pain"},{"issue":"6","key":"3917_CR63","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/iep.12373","volume":"101","author":"M Yamaguchi","year":"2020","unstructured":"Yamaguchi M, Hankinson O. An aryl hydrocarbon receptor agonist suppresses the growth of human umbilical vein endothelial cells in vitro: potent effect with polyunsaturated fatty acids. Int J Exp Pathol. 2020;101(6):248\u201363.","journal-title":"Int J Exp Pathol"},{"issue":"3","key":"3917_CR64","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1080\/03602532.2016.1197240","volume":"48","author":"O Hankinson","year":"2016","unstructured":"Hankinson O. The role of AHR-inducible cytochrome P450s in metabolism of polyunsaturated fatty acids. Drug Metab Rev. 2016;48(3):342\u201350.","journal-title":"Drug Metab Rev"},{"key":"3917_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/nu12113523","author":"M Sarparast","year":"2020","unstructured":"Sarparast M, et al. Cytochrome P450 metabolism of polyunsaturated fatty acids and neurodegeneration. Nutrients. 2020. https:\/\/doi.org\/10.3390\/nu12113523.","journal-title":"Nutrients"},{"key":"3917_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104923","volume":"159","author":"L Wan","year":"2020","unstructured":"Wan L, et al. Epoxyeicosatrienoic acids: Emerging therapeutic agents for central post-stroke pain. Pharmacol Res. 2020;159: 104923.","journal-title":"Pharmacol Res"},{"key":"3917_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2019.100788","volume":"55","author":"C Yilmaz","year":"2019","unstructured":"Yilmaz C, et al. Neurosteroids as regulators of neuroinflammation. Front Neuroendocrinol. 2019;55: 100788.","journal-title":"Front Neuroendocrinol"},{"issue":"2","key":"3917_CR68","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/glia.20910","volume":"58","author":"V Schaeffer","year":"2010","unstructured":"Schaeffer V, et al. Sciatic nerve injury induces apoptosis of dorsal root ganglion satellite glial cells and selectively modifies neurosteroidogenesis in sensory neurons. Glia. 2010;58(2):169\u201380.","journal-title":"Glia"},{"issue":"4","key":"3917_CR69","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1523\/JNEUROSCI.0324-12.2013","volume":"33","author":"XH Wei","year":"2013","unstructured":"Wei XH, et al. The upregulation of translocator protein (18 kDa) promotes recovery from neuropathic pain in rats. J Neurosci. 2013;33(4):1540\u201351.","journal-title":"J Neurosci"},{"issue":"48","key":"3917_CR70","doi-asserted-by":"publisher","first-page":"18901","DOI":"10.1073\/pnas.0809765105","volume":"105","author":"B Inceoglu","year":"2008","unstructured":"Inceoglu B, et al. Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways. Proc Natl Acad Sci USA. 2008;105(48):18901\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"3917_CR71","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12974-018-1054-3","volume":"15","author":"YL Wang","year":"2018","unstructured":"Wang YL, et al. Microglial activation mediates chronic mild stress-induced depressive- and anxiety-like behavior in adult rats. J Neuroinflammation. 2018;15(1):21.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3917_CR72","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3109\/10253899709014738","volume":"2","author":"M Schumacher","year":"1997","unstructured":"Schumacher M, et al. Neurosteroids in the Hippocampus: neuronal plasticity and memory. Stress. 1997;2(1):65\u201378.","journal-title":"Stress"},{"issue":"1\u20133","key":"3917_CR73","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0165-0173(01)00113-8","volume":"37","author":"E Plassart-Schiess","year":"2001","unstructured":"Plassart-Schiess E, Baulieu EE. Neurosteroids: recent findings. Brain Res Brain Res Rev. 2001;37(1\u20133):133\u201340.","journal-title":"Brain Res Brain Res Rev"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-03917-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-03917-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-03917-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T17:04:19Z","timestamp":1675530259000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-03917-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3917"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-03917-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]},"assertion":[{"value":"26 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Two month-old male C57BL\/6 mice (body weight 20\u201325\u00a0g) were purchased from the Animal Center of Tongji Hospital in this study. The study was conducted according to the recommendations in the Guide for the Care and Use of Laboratory Animals and under protocols approved by the Experimental Animal Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (Wuhan, China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors give consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EicOsis Human Health is a private company co-founded by BDH and has licensed several patents from the University of California on sEHI and is in human clinical trials on sEHI.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}